英文摘要 |
The monkeypox outbreak in 2022 has been the largest non-endemic outbreak since its isolation in 1958. Neglected for decades in Africa, this viral disease is mainly transmitted by men who have sexual intercourse with men, particularly those who have multiple and often anonymous partners. The monkeypox virus is transmitted through close contact, direct skin contact with virus-laden lesions, virus-containing droplets, or fomites. Unlike in previous endemic cases, patients in this outbreak have been reported to exhibit atypical symptoms: instead of systemic lesions, only local lesions around the genital and anal regions, fewer prodromal symptoms, or even asymptomatic infection. Tecovirimat, a VP37 protein inhibitor, can be administered to high-risk or severely ill patients, including children. Post-exposure prophylaxis is strongly recommended within 4 days of exposure. Both Tecovirimat and JYNNEOS, a live, attenuated non-replicating orthopoxvirus vaccine, are available from the Taiwan Centers for Disease Control. Additionally, contact and droplet isolation precautions should be taken when caring for patients with monkeypox infection. Care must be taken not to dry dust, vacuum, or sweep surfaces, as they may spread infectious particles. Wet cleaning methods, such as mopping, are preferred. |